Mark Hudson

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get REGN alerts

About Mark Hudson

Mark Hudson is recorded as Head of Investor Relations at Regeneron Pharmaceuticals, Inc. (REGN). Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.

Affiliation history

Regeneron Pharmaceuticals, Inc. (REGN)
Head of Investor Relations

Source not stated

Current

Company network

Regeneron Pharmaceuticals, Inc.

REGN

Current role

Biotechnology · Healthcare

Head of Investor Relations

Leadership on record at Regeneron Pharmaceuticals, Inc.

George D. Yancopoulos, M.D., Ph.D. Chairman
Leonard S. Schleifer, M.D., Ph.D. Chairman
Joseph J. LaRosa General Counsel
Christine A. Poon Board Member
Craig B. Thompson, M.D. Board Member
David P. Schenkein Board Member
David P. Schenkein, M.D. Board Member
Huda Y. Zoghbi, M.D. Board Member
Joseph L. Goldstein, M.D. Board Member
Kathryn Guarini Board Member

Recent activity

No call appearances or filed executive changes recorded yet.